Hanmi Pharm, the core operating company of Hanmi Group, has launched sports marketing activities leveraging the competitiveness of its over-the-counter (OTC) brands in line with the start of the professional baseball season.


Hanmi Pharm announced on April 14 that it will run consumer-targeted advertisements for its skin and nail fungal infection treatment “Mujonal” and its oral rinse “Care Gargle Solution” at Seoul’s Jamsil Baseball Stadium during the 2026 KBO professional baseball season.


With professional baseball continuing its surge in popularity—having surpassed 12 million spectators last year—the company expects these advertisements to make its products more familiar and accessible to consumers.

Advertising at Jamsil Baseball Stadium: Hanmi Pharmaceutical

Advertising at Jamsil Baseball Stadium: Hanmi Pharmaceutical

View original image

“Mujonal” will boost brand awareness through revolving rolling board ads located behind home plate, a spot that frequently appears on broadcast screens. In particular, the company is using baseball-themed slogans such as “Athlete’s Foot OUT!”, “Strike Out with Mujonal!”, and “For Athlete’s Foot, Mujonal,” to intuitively convey the product’s effectiveness in relieving symptoms of athlete’s foot.


Hanmi Pharm’s strategy is to expand product recognition and strengthen consumer engagement as an everyday OTC brand by capitalizing on the high viewership and in-person attendance during the baseball season.


Mujonal is a product lineup for treating skin and nail fungal infections, offering various formulations tailored to different symptoms and affected areas. Notably, last year the company launched “Mujonal Max Topical Solution,” the first domestic topical solution for nail fungal infections containing terbinafine hydrochloride as the main ingredient, thereby enhancing its product lineup.


Mujonal Max Topical Solution is designed for convenient use: once daily for the initial four weeks, followed by once a week thereafter.


“Mujonal S Nail Lacquer” contains ciclopirox as its main ingredient and features a light-shielding, airtight container to prevent loss of efficacy.


“Mujonal Cream” and “Mujonal Cool Cream” are used to treat skin fungal infections and are based on the antifungal agent terbinafine hydrochloride. In particular, Mujonal Cool Cream contains lidocaine and L-menthol, which can help relieve itching and pain.

Four types of Mujonal, a treatment for skin and nail fungal infections from Hanmi Pharmaceutical. From the left, Mujonal Max Topical Solution, Mujonal Cream, Mujonal Cool Cream, Mujonal S Nail Lacquer. Hanmi Pharmaceutical

Four types of Mujonal, a treatment for skin and nail fungal infections from Hanmi Pharmaceutical. From the left, Mujonal Max Topical Solution, Mujonal Cream, Mujonal Cool Cream, Mujonal S Nail Lacquer. Hanmi Pharmaceutical

View original image

Additionally, Hanmi Pharm is increasing brand exposure by running advertisements for its OTC oral rinse, “Care Gargle Solution,” during this baseball season. The Care Gargle Solution ads are displayed on LED electronic billboards in the spectator stands.


The Care Gargle Solution advertisement delivers a clear message to both stadium spectators and television viewers via the LED billboards, highlighting the product's ability to effectively manage oral bacteria with the slogan, “Bacteria Attack in Your Mouth, OUT with Care Gargle.”


A Hanmi Pharm representative stated, “This campaign is designed to help consumers more easily recognize the features and efficacy of our products by linking them with the highly popular sport of baseball. We will continue to expand consumer touchpoints with OTC medicines that are easily accessible in everyday life.”



Mujonal and Care Gargle Solution are distributed to pharmacies nationwide via Online Pharm, a healthcare-focused distribution company affiliated with Hanmi Science. As OTC medicines, they are available for purchase directly by consumers without a prescription.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing